CDC in Kenya: Why We're Here
CDC's Impact in Kenya
- 3.6 million people received HIV counseling and testing results in 2013
Of 8.8 million under PEPFAR Kenya
- 643,000 houses sprayed and 2,435,000 people protected from malaria in four target districts as part of the President’s Malaria Initiative in 2012
- 30,000 HIV-positive pregnant women received a full course of antiretroviral prophylaxis in 2013
Of 55,000 under PEPFAR Kenya
- 346,000 individuals received antiretroviral therapy, including 34,000 children, in 2013
Of 631,000, including 63,000 children, under PEPFAR Kenya
- 145,000 voluntary medical male circumcisions to reduce HIV risk were performed in 2013
Of 215,000 under PEPFAR Kenya
- 1,300 individuals are enrolled into two phase III malaria vaccine trials of one of the most promising vaccines
- 58,000 people participate in surveillance for respiratory, jaundice, febrile, and diarrheal conditions
- 225,000 people are part of a health and demographic surveillance system that collects health and demographic information every four months
CDC Kenya’s mission is to protect and improve health in Kenya and the region through science, policy, partnership, and evidence-based public health action. In Kenya, where over 43% of the population lives in poverty, health challenges include high maternal and child mortality and a high burden of infectious diseases such as HIV, tuberculosis, and malaria. In this context, CDC Kenya works in close partnership with the government of Kenya and other local, national and regional partners to address the burden of disease in Kenya and improve its health systems.
Building public health capacity in partner countries, improving health security globally, and collaborating with partners to impact the health and wellbeing of people around the world is an exceptional investment.